An Indian industrialist wants to buy Biogaran, the French number one in generics
The share price of Aurobindo Pharma fell in the early trade on April 8 after the company received three observations on its Andhra Pradesh subsidiary.
Aurobindo Pharma Limited has commissioned four state-of-the-art manufacturing facilities for PenicillinG, 6-Amino Penicillanic Acid (6-APA), Injectable products and Granulation, through its wholly owned subsidiaries, the company informed the Stock Exchange.
Aurobindo Pharma on Thursday said the deadline for negotiations between its arm CuraTeQ Biologics and Merck Sharp & Dohme Singapore for contract manufacturing operations for biologicals has been extended till May next year. Last year in October, CuraTeQ Biologics Pvt Ltd and Merck Sharp & Dohme Singapore Trading Pte Ltd and its affiliates (MSD) had signed a letter of intent (LoI) for contract manufacturing operations (CMO) for biologicals, whereby the parties intended to conclude the negotiations by March 31, 2024.
Aurobindo Pharma`s Generic Acetaminophen:Ibuprofen Receives Approval in the U.S.
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Mometasone Furoate Monohydrate Nasal Spray, 50 mcg/spray, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Nasonex Nasal Spray, 50 mcg/spray of Organon LLC. The product will be launched in Q1FY25.
After a pause, Aurobindo resumes drug shipments from India plant
Aurobindo Pharma`s Generic Mycophenolic Sodium Receives Approval in the U.S.